SCHEMBL369665

SCHEMBL369665

COc1ccc(C(=O)C=Cc2cc(F)cc(F)c2)cn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.65
MAOB P27338 1/20 0.65
SMN1; SMN2 Q16637 4/20 0.52
KRAS P01116 2/20 0.52
ALDH1A1 P00352 1/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NPC1 O15118 2/20 0.52
LMNA P02545 2/20 0.52
RAB9A P51151 2/20 0.52
KMT2A Q03164 2/20 0.52
NNMT P40261 1/20 0.49
CXCL12 P48061 1/20 0.47
CYP1A1 P04798 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP1B1 Q16678 2/20 0.45
CYP2D6 P10635 1/20 0.45
GPR183 P32249 1/20 0.45
KCNH2 Q12809 1/20 0.45
ABCG2 Q9UNQ0 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL369664 1.00 MAOA (0.65) MAOAMAOBSMN1; SMN2KRASALDH1A1
SCHEMBL369545 0.84 MAOB (0.80) MAOAMAOBSMN1; SMN2KRASKMT2A
SCHEMBL363510 0.84 MAOB (0.80) MAOAMAOBSMN1; SMN2KRASKMT2A
SCHEMBL1390185 0.80 GPR183 (0.66) MAOAMAOBKRASALDH1A1L3MBTL1
SCHEMBL1390666 0.79 MAOB (0.58) MAOAMAOBSMN1; SMN2KRASALDH1A1
SCHEMBL1390340 0.78 MAOB (0.66) MAOAMAOBALDH1A1NPC1LMNA
SCHEMBL1390372 0.78 MAOB (0.54) MAOAMAOBSMN1; SMN2NPC1LMNA
SCHEMBL1390301 0.78 MAOB (0.55) MAOAMAOBSMN1; SMN2ALDH1A1ATM
SCHEMBL1390413 0.77 MAOA (0.51) MAOAMAOBSMN1; SMN2KRASALDH1A1
SCHEMBL1390298 0.77 MAOB (0.65) MAOAMAOBSMN1; SMN2ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 MAOA 2715/4885MAOB 1814/4885SMN1; SMN2 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.